Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

Analytical Biochemistry

Volumn 341, Issue 2, 2005, Pages 241-250

  Jacobs, Esther M G ^a   Hendriks, Jan C M ^a   Van Tits, Berry L J H ^a   Evans, Patricia J ^b   Breuer, William ^c   Ding, Yong Liu ^d   Jansen, Eugene H J M ^e   Jauhiainen, Katri ^f   Sturm, Brigitte ^g   Porter, John B ^b   Scheiber Mojdehkar, Barbara ^g   Von Bonsdorff, Leni ^f   Cabantchik, Z Ioav ^c   Hider, Robert C ^d   Swinkels, Dorine W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f FINNISH RED CROSS BLOOD SERVICE   (Finland)

^g UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bleomycin; Chelator; Iron overload; Non transferrin bound iron; NTBI; Round robin

Indexed keywords

CHELATION; DIAGNOSIS; PEPTIDES; STANDARDIZATION;

BLEOMYCINS; CHELATOR; IRON OVERLOADS; NTBI; ROUND ROBIN;

IRON;

BLEOMYCIN; IRON CHELATING AGENT; ISOPROTEIN; TRANSFERRIN BINDING PROTEIN;

ARTICLE; BLOOD SAMPLING; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; IRON KINETICS; IRON OVERLOAD; LABORATORY; MEDICAL INFORMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REGRESSION ANALYSIS; REPRODUCIBILITY; STANDARDIZATION; TRANSFERRIN BLOOD LEVEL;

EID: 21144452241     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2005.03.008     Document Type: Article

References (25)

1. P.T. Lieu, M. Heiskala, P.A. Peterson, and Y. Yang The roles of iron in health and disease Mol. Aspects Med. 22 2001 1 87
2. W. Breuer, C. Hershko, and Z.I. Cabantchik The importance of non-transferrin bound iron in disorders of iron metabolism Transfus. Sci. 23 2000 185 192
3. M. Grootveld, J.D. Bell, B. Halliwell, O.I. Aruoma, A. Bomford, and P.J. Sadler Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis: characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy J. Biol. Chem. 264 1989 4417 4422
4. C. Hershko, G. Link, and I. Cabantchik Pathophysiology of iron overload Ann. N.Y. Acad. Sci. 850 1998 191 201
5. W.C. Wang, N. Ahmed, and M. Hanna Non-transferrin-bound iron in long-term transfusion in children with congenital anemias J. Pediatr. 108 1986 552 557
6. L. McNamara, A.P. MacPhail, E. Mandishona, P. Bloom, A.C. Paterson, T.A. Rouault, and V.R. Gordeuk Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload J. Gastroenterol. Hepatol. 14 1999 126 132
7. M. Durken, P. Nielsen, S. Knobel, B. Finckh, C. Herrnring, B. Dresow, B. Kohlschutter, M. Stockschlader, W.H. Kruger, A. Kohlschutter, and A.R. Zander Nontransferrin-bound iron in serum of patients receiving bone marrow transplants Free Radic. Biol. Med. 22 1997 1159 1163
8. O.I. Aruoma, A. Bomford, R.J. Polson, and B. Halliwell Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy Blood 72 1988 1416 1419
9. R.C. Hider Nature of non-transferrin-bound iron Eur. J. Clin. Invest. 32 Suppl. 2002 50 54
10. B. de Valk, M.A. Addicks, I. Gosriwatana, S. Lu, R.C. Hider, and J.J. Marx Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes Eur. J. Clin. Invest. 30 2000 248 251
11. G. Fiorelli, T.M. De Feo, L. Duca, D. Tavazzi, I. Nava, S. Fargion, and M.D. Cappellini Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis Eur. J. Clin. Invest. 32 Suppl. 2002 21 27
12. B. de Valk, and J.J. Marx Iron, atherosclerosis, and ischemic heart disease Arch. Int. Med. 159 1999 1542 1548
13. A.C. Chua, J.K. Olynyk, P.L. Leedman, and D. Trinder Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis Blood 104 2004 1519 1525
14. M.P. Kooistra, S. Kersting, I. Gosriwatana, S. Lu, J. Nijhoff-Schutte, R.C. Hider, and J.J.M. Marx Non-transferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion Eur. J. Clin. Invest. 32 Suppl. 2002 36 41
15. G.J. Anderson Non-transferrin-bound iron and cellular toxicity J. Gastroenterol. Hepatol. 14 1999 105 108
16. I. Gosriwatana, O. Loreal, S. Lu, P. Brissot, J. Porter, and R.C. Hider Quantification of non-transferrin-bound iron in the presence of unsaturated transferring Anal. Biochem. 273 1999 212 220
17. O. Loreal, I. Gosriwatana, D. Guyader, J. Porter, P. Brissot, and R.C. Hider Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method J. Hepatol. 32 2000 727 733
18. L. von Bonsdorff, E. Lindeberg, L. Sahlstedt, J. Lehto, and J. Parkkinen Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies Clin. Chem. 48 2002 307 314
19. W. Breuer, A. Ronson, I.N. Slotki, A. Abramov, C. Hershko, and Z.I. Cabantchik The assessment of serum non-transferrin-bound iron in chelation therapy and iron supplementation Blood 95 2000 2975 2982
20. W. Breuer, and Z.I. Cabantchik A fluorescence-based one-step assay for serum non-transferrin-bound iron Anal. Biochem. 299 2001 194 202
21. B.P. Esposito, W. Breuer, P. Sirankapracha, P. Pootrakul, C. Hershko, and Z.I. Cabantchik Labile plasma iron in iron overload: redox activity and susceptibility to chelation Blood 102 2003 2670 2677
22. J.M. Bland, and D.G. Altman Measuring agreement in method comparison studies Stat. Methods Med. Res. 8 1999 135 160
23. B.B. Hasinoff The intracellular iron sensor calcein is catalytically oxidatively degraded by iron(II) in a hydrogen peroxide-dependent reaction J. Inorg. Biochem. 95 2003 157 164
24. L. Sahlstedt, L. von Bonsdorff, F. Ebeling, T. Ruutu, and J. Parkkinen Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients Br. J. Haematol. 119 2002 547 553
25. P. Pootrakul, W. Breuer, M. Sametband, P. Sirankapracha, C. Hershko, and Z.I. Cabantchik Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron overloaded beta-thalassaemia/HbE patients treated with an oral chelator Blood 104 2004 1504 1510